Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 18;9(11):e3911.
doi: 10.1097/GOX.0000000000003911. eCollection 2021 Nov.

An Advanced Surgical Dressing for High-risk Patients Undergoing Breast Cancer Surgery: a Case-control Study

Affiliations

An Advanced Surgical Dressing for High-risk Patients Undergoing Breast Cancer Surgery: a Case-control Study

A Nicotera et al. Plast Reconstr Surg Glob Open. .

Abstract

Oncological breast surgeries, classified as breast conserving surgery, oncoplastic surgery, and mastectomies (standard or with tissue sparing and reconstruction), are burdened with an overall complication rate up to 33%. Aquacel Ag Surgical is a combined hydrofiber-hydrocolloids dressing. The aim of this study is to evaluate the incidence of surgical site complications in patients presenting with three or more risk factors (or two, of which at least one classified as "high risk"), undergoing breast cancer surgery with/without reconstruction, comparing advanced (Aquacel Ag Surgical) with traditional dressing.

Methods: This is a retrospective, monocentric, case-control study based at the breast unit of the Città della Salute e della Scienza Hospital of Turin, Italy. Forty-two patients who underwent breast surgeries and met the inclusion criteria were enrolled, from February 1 to July 31, 2018. The primary endpoint was comparing the incidence of surgical site complications (skin alterations, infection, and wound dehiscence) in the two groups. The secondary endpoints were evaluating patient's quality of life, aesthetic outcomes, and compliance to the dressings.

Results: The distribution of risk factors at the baseline between the two groups was balanced, without statistically significant differences. Wound complications' incidence at 1 week was lower in the advanced dressing group (P = 0.015). On the bivariate descriptive analysis, advanced dressing proved to be easier to remove for the operator (P = 0.026). The aesthetic outcomes vouched for better scores in the advanced dressing group.

Conclusion: In the presented study Aquacel Ag Surgical dressing reduces surgical site complications in the first week after surgery in patients affected by three or more risk factors (or two with at least one classified as "high risk").

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Study design. SF 36: Short Form 36.
Fig. 2.
Fig. 2.
Patient risk factors in the two groups.
Fig. 3.
Fig. 3.
Risk factors related to the type of surgery in the two groups. n-BCS: non-breast conserving surgery (oncoplastic surgeries and mastectomies with or without reconstructions).
Fig. 4.
Fig. 4.
Number of patients with surgical site complications 1 week, 1 month, 6 months, and 24 months after surgery.

References

    1. Vitug AF, Newman LA. Complications in breast surgery. Surg Clin North Am. 2007;87:431–451, x. - PubMed
    1. Sullivan SR, Fletcher DRD, Isom CD, et al. . True incidence of all complications following immediate and delayed breast reconstruction. Plast Reconstr Surg. 2008;122:19–28. - PubMed
    1. Hultman CS, Daiza S. Skin-sparing mastectomy flap complications after breast reconstruction: review of incidence, management, and outcome. Ann Plast Surg. 2003;50:249–55; discussion 255. - PubMed
    1. Carlson GW, Bostwick J, III, Styblo TM, et al. . Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann Surg. 1997;225:570– 57–5.; discussion 575. - PMC - PubMed
    1. Padubidri AN, Yetman R, Browne E, et al. . Complications of postmastectomy breast reconstructions in smokers, ex-smokers, and nonsmokers. Plast Reconstr Surg. 2001;107:342– 34–9.; discussion 350. - PubMed